<DOC>
	<DOC>NCT02608554</DOC>
	<brief_summary>The present study is a randomized controlled trial, overweight/obese adolescent and young PCOS subjects will be assigned into two groups: Taichi arm and control arm. Hormonal profile and metabolic profile will be determined.</brief_summary>
	<brief_title>Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Women aged between 19 and 35 years; Diagnosis of PCOS according to the modified Rotterdam criteria; 2 years after menarche; Body mass index (BMI) equal to or greater than 23 kg/m*m. Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropinreleasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, antiobesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers. Patients with other endocrine disorder including 21hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome. Patients with known severe organ dysfunction or mental illness.</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Polycystic ovary sybdrome</keyword>
	<keyword>Taichi</keyword>
</DOC>